Ethical perspectives of fertility preservation through experts’ opinions - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Expert Insights on the Ethical Considerations of Fertility Preservation

  • By

  • Silviya Aleksandrova-Yankulovska

  • Marcin Orzechowski

  • Katharina Hancke

  • Karin Bundschu

  • Florian Steger

  • September 8, 2026

Share

Clinical Report: Expert Insights on the Ethical Considerations of Fertility Preservation

Background

Fertility preservation technologies have evolved to assist various populations, including cancer patients and healthy women seeking to delay childbearing. Understanding the ethical considerations surrounding these technologies is crucial for ensuring equitable access and informed decision-making among patients. The implications of these technologies extend beyond medical outcomes, impacting patients' reproductive rights and future family planning.

Data Highlights

No numerical data or trial data presented in the article.

Key Findings

  • Experts support age-appropriate involvement of children in fertility preservation decisions.
  • Most experts oppose postmortem reproduction but agree on the importance of providing information about it.
  • Medical benefits and risks of fertility preservation are prioritized over social considerations.
  • Access to fertility preservation should be available to all patient groups, including those seeking it for non-medical reasons.
  • Health insurance coverage for fertility preservation is unanimously supported only for medical indications.

Clinical Implications

Healthcare providers should ensure that patients receive comprehensive information about fertility preservation options, including the risks and benefits. Informed consent processes must be tailored to the patient's circumstances and decision-making capacity, particularly for minors and vulnerable populations.

Conclusion

Fertility preservation decisions have significant implications for patients' reproductive futures. Ensuring equitable access and informed consent is essential in navigating the ethical landscape of these technologies.

Related Resources & Content

  1. American Society for Reproductive Medicine, ASRM, 2026 -- Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion
  2. American Society for Reproductive Medicine, ASRM, 2026 -- Fertility preservation in patients with medical indications: a committee opinion
  3. Frontiers in Reproductive Health — Ethics of non-oncological fertility preservation from the perspective of the four principles of bioethics
  4. Frontiers in Endocrinology — Ethical considerations and management strategies for fertility preservation in women of reproductive age with malignant tumors: Chinese practices and perspectives
  5. The ASCO Post — Options for Preserving Fertility Should Be Considered Early to Maximize the Likelihood of Success
  6. Bone Marrow Transplantation — Fertility preservation in 2026: current landscape in Europe and the United States for children and adolescents undergoing hematopoietic stem cell transplantation—recommendations on behalf of the Westhafen Intercontinental Group
  7. Ethics of non-oncological fertility preservation from the perspective of the four principles of bioethics
  8. Options for Preserving Fertility Should Be Considered Early to Maximize the Likelihood of Success
  9. Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion (2018) | American Society for Reproductive Medicine | ASRM
  10. Fertility preservation in patients with medical indications: a committee opinion (2026) | American Society for Reproductive Medicine | ASRM
  11. NG257 Fertility problems: assessment and treatment: Evidence review R 31/03/2026

Original Source(s)

Related Content